Transplantation of HSPCs into fumarylacetoacetate hydrolase (Fah)-deficient mice showed that they could transdifferentiate into functional hepatocytes, leading to the regeneration of the injured liver, thus correcting the phenotype in a mouse model of human tyrosinemia type I [65]. Here, FAH is linked to tyrosinemia type I.